US 8394380
Compositions and methods for alzheimer's disease
granted A61KA61K2039/505A61P
Quick answer
US patent 8394380 (Compositions and methods for alzheimer's disease) held by Primex Clinical Laboratories, Inc. expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Primex Clinical Laboratories, Inc.
- Grant date
- Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61P, A61P25/28